Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Aug 26;11(1):17226.
doi: 10.1038/s41598-021-96480-8.

Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients

Affiliations
Observational Study

Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients

Sakiko Soutome et al. Sci Rep. .

Abstract

Tooth extraction has been avoided since it has been considered a major risk factor for medication-related osteonecrosis of the jaw (MRONJ). However, MRONJ may also develop from tooth that is an infection source. This study aimed to clarify whether tooth extraction is a risk factor for the development of MRONJ in cancer patients receiving bone-modifying agents (BMAs). This retrospective observational study included 189 patients (361 jaws) from two hospitals. The risk factors of MRONJ were identified by comparing patient characteristics between those who did and did not develop MRONJ. Furthermore, the effect of tooth extraction during BMA therapy was analyzed after adjusting for confounding factors using the propensity score matching method. MRONJ occurred in 33 patients jaws. A longer duration of BMA administration, fewer number of teeth, presence of symptoms of local infection, and infected teeth were independent risk factors of MRONJ. However, tooth extraction during BMA therapy did not increase the risk. Propensity score matching analysis showed that tooth extraction significantly lowered the risk of MRONJ development. Teeth that can be an infection source increases the risk of MRONJ, and thus, they need to be extracted even during BMA administration.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Cumulative occurrence rate of MRONJ. The incidence of MRONJ increases over time, and the 1-, 2-, 3-, 4-, and 5-year cumulative occurrence rates are 8.1%, 14.7%, 18.2%, 18.2%, and 23.3%, respectively.
Figure 2
Figure 2
Relationship between tooth extraction and development of MRONJ. (A): Overall, MRONJ occurs earlier when tooth extraction is performed, although there is no significant difference in MRONJ incidence between the extraction and no-extraction groups. (B). After propensity score matching, the incidence of MRONJ is higher in the no-extraction group, indicating that tooth extraction significantly lowers the risk of MRONJ.
Figure 3
Figure 3
Schema for dental intervention in patients receiving high-dose BMA.

References

    1. Ruggiero SL, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J. Oral Maxillofac. Surg. 2014;72:1938–1956. doi: 10.1016/j.joms.2014.04.031. - DOI - PubMed
    1. Saad F, et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann. Oncol. 2012;23:1341. doi: 10.1093/annonc/mdr435. - DOI - PubMed
    1. Yoneda T, et al. Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J. Bone Miner. Metab. 2017;35:6–19. doi: 10.1007/s00774-016-0810-7. - DOI - PubMed
    1. Barasch A, et al. Risk factors for osteonecrosis of the jaws: A case-control study from the CONDOR Dental PBRN. J. Dent. Res. 2011;90:439–444. doi: 10.1177/0022034510397196. - DOI - PMC - PubMed
    1. Kyrgidis A, et al. Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients. J. Clin. Oncol. 2008;26:4634–4638. doi: 10.1200/JCO.2008.16.2768. - DOI - PubMed

Publication types

MeSH terms